Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 97

Results For "IFF"

1272 News Found

Velocity Clinical Research invests in Indian tech, acquires TrierHealth
Biotech | February 22, 2022

Velocity Clinical Research invests in Indian tech, acquires TrierHealth

The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials


CanSinoBIO's Convidecia approved as heterologous booster in China
News | February 21, 2022

CanSinoBIO's Convidecia approved as heterologous booster in China

Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants


Sputnik Light gets a boost as China changes rules on boosters
News | February 21, 2022

Sputnik Light gets a boost as China changes rules on boosters

Sputnik Light can become a major booster for those vaccinated with inactivated Chinese Covid-19 vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters


Gujarat unveils ambitious Biotech Policy 2022-27
Policy | February 21, 2022

Gujarat unveils ambitious Biotech Policy 2022-27

According to the state government, it will also provide support to special projects such as preclinical testing, genome sequencing in the private sector, private sector BSL-3 lab-vaccine development and manufacturing and testing and certification laboratories


Indian pharma industry needs a winning partnership
News | February 19, 2022

Indian pharma industry needs a winning partnership

The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines


USFDA accepts Mirati Therapeutics' New Drug Application for Adagrasib
Drug Approval | February 18, 2022

USFDA accepts Mirati Therapeutics' New Drug Application for Adagrasib

The Prescription Drug User Fee Action (PDUFA) date for adagrasib is December 14, 2022


Rajiv Gupta to retire as chairman of Avantor
News | February 17, 2022

Rajiv Gupta to retire as chairman of Avantor

Gupta to retire at the end of his current term on May 12, 2022, after more than a decade of service, during which time Avantor has transformed into a global life sciences leader


Centauri Therapeutics closes £ 24 million Series A investment round
Startup | February 17, 2022

Centauri Therapeutics closes £ 24 million Series A investment round

Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform


USFDA accepts for Priority Review Bristol Myers Squibb’s Supplemental BLA for Breyanzi
Biotech | February 17, 2022

USFDA accepts for Priority Review Bristol Myers Squibb’s Supplemental BLA for Breyanzi

Application based on the pivotal Phase 3 TRANSFORM study in which Breyanzi showed significant and clinically meaningful improvements over salvage chemotherapy followed by high-dose chemotherapy plus autologous stem cell transplant, which has been the standard of care for more than 20 years


Clean Science and Technology to invest Rs. 300 - 500 Cr on expansion
News | February 16, 2022

Clean Science and Technology to invest Rs. 300 - 500 Cr on expansion

The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals